Evidence map›Paper›PMID 29057800›Full record

ArticleMolecules (Basel, Switzerland)2017

Novel Bioactive Paulomycin Derivatives Produced by Streptomyces albus J1074.

Jorge Fernández-De la Hoz, Carmen Méndez, José A Salas, Carlos Olano

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Identification of Antimicrobial Compounds in TwoFrontiers in microbiology · 2022
    Article
  5. Article
  6. Article
  7. Comparative Genomics of Marine Sponge-DerivedFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jorge Fernández-De la HozDepartamento de Biología Funcional e Instituto Universitario de Oncología del Principado de Asturias (I.U.O.P.A), Universidad de Oviedo, C/Julian Claveria s/n, 33006, Oviedo (Asturias), Spain. jorgefhoz@gmail.com.ORCID 0000-0002-6047-6532
Carmen MéndezDepartamento de Biología Funcional e Instituto Universitario de Oncología del Principado de Asturias (I.U.O.P.A), Universidad de Oviedo, C/Julian Claveria s/n, 33006, Oviedo (Asturias), Spain. cmendezf@uniovi.es.
José A SalasDepartamento de Biología Funcional e Instituto Universitario de Oncología del Principado de Asturias (I.U.O.P.A), Universidad de Oviedo, C/Julian Claveria s/n, 33006, Oviedo (Asturias), Spain. jasalas@uniovi.es.
Carlos OlanoDepartamento de Biología Funcional e Instituto Universitario de Oncología del Principado de Asturias (I.U.O.P.A), Universidad de Oviedo, C/Julian Claveria s/n, 33006, Oviedo (Asturias), Spain. olanocarlos@uniovi.es.ORCID 0000-0001-5440-3540

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Four novel paulomycin derivatives have been isolated from

Indexed as

Anti-Bacterial AgentsCyclohexenesDisaccharidesGram-Negative BacteriaGram-Positive BacteriaHumansStreptomycesThiazolesAnti-Bacterial AgentsCyclohexenesDisaccharidespaulomenol Bpaulomycin AThiazolesantibiotic 273a2paulic acidpaulomenolstructural analoguethiazole moiety

Identifiers

PMID29057800
PMCPMC6151807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.